Syrma SGS — an electronics contract-maker climbing the value ladder

The Short Version

Syrma SGS is a factory-for-hire: it designs and builds electronic products and circuit boards that other companies sell under their own brands — for cars, factory equipment, medical devices, consumer gadgets and more. The year just ended (FY26) was its best by a distance: revenue up 27% to ₹4,857 crore and profit up 87% to ₹346 crore, with profit margins climbing from a thin ~6% two years ago to about 11–12%. The reason the profit grew more than twice as fast as sales is the heart of the story — Syrma is deliberately shifting from low-value assembly toward higher-value, design-led work, and quietly walking away from cheap, low-margin business. Along the way it turned net-cash, got a credit-rating upgrade, and placed two big bets for the future: a defence-electronics business and a plant to make bare circuit boards in India (something the country imports almost entirely today). The stock prices in a lot of this optimism, at around 74 times earnings.

What This Company Actually Does

Most electronics brands don’t own factories. When a carmaker needs the electronic control unit behind its fuel-injection system, or a medical-device company needs its monitor assembled, or a utility needs smart electricity meters built, they hand the job to an EMS company — “electronics manufacturing services,” the contract factory of the electronics world. Syrma SGS, based in Chennai and born from the merger of two veteran electronics firms (the Tandon Group’s Syrma and the automotive-focused SGS Tekniks), is one of India’s larger ones.

The single most important thing to understand is where on the value ladder an EMS firm sits. At the bottom is build-to-print — the customer hands over a finished design and Syrma simply buys the parts and assembles them. High volume, but razor-thin margins, because Syrma adds only its hands, not its brain. At the top is ODM / build-to-spec — the customer describes what they need and Syrma does the design and engineering itself, owning more of the intellectual property and keeping a fatter margin. Syrma’s whole strategy is to climb from the first toward the second, and the proof is in the numbers: its ODM share rose from 12% to 17% of sales in a single year, an 80% jump in absolute terms.

It serves a deliberately diversified spread of end-markets — automotive (especially the electronics-heavy EV and safety-systems shift), industrial (smart meters, power equipment, data-centre boards), healthcare/medical devices (almost all design-led, high-margin), consumer, IT (laptops, motherboards), railways, and now defence. The founding Tandon family runs it, though promoters have sold down from ~47% to ~42% over two years, with Indian mutual funds buying the shares (up from 6% to 17%). The business is now conservatively financed — net cash of ₹467 crore, debt cut to ₹353 crore, and a credit-rating upgrade to AA during the year.

One structural feature to keep in mind: EMS is working-capital-heavy. Syrma buys components, holds inventory, builds product, and waits to be paid — so cash routinely gets tied up, and how well it manages that cycle matters as much as the profit line.

The Long Game

Syrma is riding a genuine national tailwind — India’s push to manufacture electronics domestically rather than import them — and management runs the company against three numbers it repeats every quarter: revenue growth, EBITDA (operating profit), and operating cash flow. The medium-term ambition is to compound revenue at 30–35% a year, organically plus through acquisitions, while lifting margins as the mix improves.

Three engines drive the long game:

The mix climb. Growing the high-margin verticals (industrial, automotive, medical, exports) and design-led ODM work, while capping the low-margin consumer business below 35% of sales. This is what turned a flat-profit company (FY23–FY24 profit was stuck near ₹124 crore despite revenue nearly doubling) into FY26’s breakout.
Defence (Elcome). Mid-year, Syrma bought 60% of Elcome, a ~47-year-old defence-electronics maker (navigation, surveillance, communication for the armed forces) doing ~₹280–300 crore of revenue at a rich 20–25% margin. Defence is lumpy and cash-hungry but high-margin and sticky — a new leg expected to contribute meaningfully from FY27.
The PCB bet — the big one. Syrma is building a plant to manufacture bare printed circuit boards (PCBs) — the green boards inside every electronic device. India makes almost none of these today (roughly 90% are imported), so this is an import-substitution play backed by government incentives (the “ECMS” scheme) and large state subsidies. The first phase costs ~₹400 crore (total envelope ~₹800 crore, eventually ~₹1,500 crore including advanced board types), commissions around end-FY27/early FY28, and starts earning from FY28. If it works, it adds a whole new business on top of the EMS one; management says FY28 growth should be “superior to 30–35%” once PCB kicks in.

The case for giving it time is the execution record (see below — management has consistently beaten its own raised guidance) and the structural demand. The case for realism is the price (~74× earnings leaves no room for stumbles), the working-capital intensity, and the fact that the PCB plant is still a capex promise, not yet a profit.

The Year, Told Simply

The thread through FY26: margins inflected sharply upward, management kept raising its own guidance and beating it, and it spent the year planting seeds (defence, PCB, new customers) for the next phase.

First quarter (reported July). A strong start — profit up 145% — and management raised the full-year margin guidance from ~8% to 8.5–9%, while reaffirming 30–35% revenue growth. The strategic news: a new joint venture to make bare PCBs (with a Korean technology partner), entering a market that’s 90% imported. Consumer revenue was being deliberately wound down to lift the mix.

Second quarter (reported November). Margins held above 10%, and management said it would now exceed the raised 8.5–9% guidance. This was the busy quarter for deal-making: it announced four moves at once — buying 60% of defence-electronics firm Elcome, a railway-focused JV with Italy’s Elemaster, government approval for the PCB plant, and a solar-inverter acquisition (KSolare). It also flagged eight new customers worth ~$100 million of potential revenue and one framework contract worth ~$250 million over three years.

Third quarter (reported January). The margin breakout became undeniable — operating margin hit 12.6% and management raised guidance a third time, now targeting ₹500 crore-plus of operating profit for the year (up from ₹324 crore the prior year, ~55% growth against an original 30% target). It was candid where things lagged: smart-meter revenue was cut from a ₹300 crore target to ~₹200 crore because that business ties up too much cash for its thin margin — a telling example of the company choosing margin and cash discipline over chasing top-line.

Fourth quarter and the year (reported May). A record finish — Q4 revenue up 56% — closing FY26 at ₹4,857 crore (+27%) and ₹346 crore profit (+87%), with operating margin at ~12%, net cash on the balance sheet, and the rating upgraded to AA. Two honest notes: management dropped the KSolare solar acquisition (the seller failed to meet conditions — a sign of deal discipline rather than deal-hunger), and for FY27 it guided conservatively to 35% revenue growth but only 10.5–11% margin (despite delivering ~12%), citing global trade volatility and shipping disruption from the Middle East crisis — explicitly saying it would revise upward if things stabilised.

The pattern a long-term investor should appreciate: this is a management team that under-promises and over-delivers — it raised guidance three times in one year and beat each mark — and that visibly prizes margin and cash discipline over vanity growth (winding down consumer, trimming smart meters, walking away from an acquisition). The flip side: nearly every lever is already working, so the rich valuation is paying for continued flawless execution plus the unproven PCB bet.

What a Patient Investor Would Watch

On a known multi-year clock. The ODM mix continuing to climb (it owns more IP and margin at the design-led end). The PCB plant — commissioning around end-FY27, first revenue FY28, the single biggest new growth engine and the biggest execution risk. The defence (Elcome) business scaling from ~₹300 crore at 20–25% margins. Medical devices crossing ₹500 crore. And the margin path — management’s conservative 10.5–11% FY27 guide against a ~12% FY26 delivery, with an explicit promise to revise up if conditions allow.

What could genuinely matter. Working capital is the structural watch-item for any EMS: management says its net cycle actually improved to ~63 days in FY26, but receivables remain stretched (near 140 days) and the broader screener metric shows working-capital days rising — the honest read is that the company is managing it deliberately (even sacrificing growth to protect it), but it bears watching as defence and new verticals (which carry longer cash cycles) scale. The valuation (~74× earnings, ~8× book, near a 52-week high) leaves no margin for a stumble. The promoter sell-down from 47% to 42% has no stated explanation. The PCB project is a multi-year, ₹800-crore-plus capex bet still to prove its returns. And new competition is coming — large players (L&T, among others) are entering Indian electronics manufacturing.

The simple test for next year. Did revenue grow ~35% and operating profit reach the ₹700 crore target? Did margins hold near or above the 10.5–11% guide? Did the ODM/high-margin mix keep climbing? Did the PCB plant stay on track for FY28? Did working capital stay disciplined as defence scaled? Five questions, all answerable from next year’s filings — from a management with a one-year track record of beating exactly these marks.

The Four Checks

1. Quality and moat. A genuinely improving business, but the moat is thin and still under construction. Contract electronics manufacturing is, at its core, a contestable trade — the customer owns the brand and usually the design, and Syrma’s edge rests on customer qualification (especially in automotive and medical, where switching a supplier means re-certifying), four decades of manufacturing heritage, and a rising share of design-led ODM work where it owns more of the IP. That ODM share is 17% of revenue — meaningful and growing fast, but 83% of the business is still services others could in principle replicate, and large rivals (L&T’s ₹5,000 crore electronics foray, among others) are entering exactly this space. The PCB plant could add a more structural advantage — India imports ~90% of bare boards, and government subsidies raise the entry barrier — but it isn’t built yet. Call it a decent business with real stickiness in pockets, not a fortress.

2. Returns on incremental capital and runway. Moderate returns, long runway. ROCE has travelled 15% → 10% → 12% → 17% over FY22–FY26 — the dip was the low-margin volume sprint, the recovery is the mix climb — and ROE sits at 13.9%, with the three-year average still a modest 10.6%. So the rupee reinvested earns mid-teens at best, and only recently. What the engine has going for it is the runway: India’s electronics-manufacturing substitution is a multi-year tailwind, management is guiding 30–35% growth into FY27 and beyond, and the ₹800 crore-plus PCB programme plus defence give it large, identified places to deploy capital. The open question is whether the new capital (PCB especially) earns the improved 17%, the old 10–12%, or something better — the FY26 number is one good year, not yet a proven rate.

3. Capital allocation for the stage. Mostly what you’d want from a company at this stage, with the standard growth-phase caveats. Management is reinvesting hard — ₹140 crore of FY26 capex rising to ₹350–400 crore in FY27 — while cutting debt by a third to ₹353 crore, turning net-cash (₹467 crore), and earning a rating upgrade to AA. The discipline shows in what it declined: consumer capped below 35% of sales, smart-meter revenue deliberately trimmed because it ties up cash, and the KSolare acquisition dropped when the seller missed conditions. The quibbles: growth has been funded partly by equity (the FY23 IPO, then a fresh raise in FY26 — equity capital rose from ₹178 to ₹193 crore with a sharp jump in reserves), FY22–FY24 burned cash with free cash flow hitting -₹451 crore, the dividend is token (payout down to 9%), and there is no buyback history visible in the data — though at this price none would make sense. Rational for the stage; not yet tested in the return-cash phase.

4. Price. Demanding. As of the June 2026 snapshot, the stock trades at ₹1,248 — a ₹24,068 crore market cap, 75 times earnings, 8.4 times book, near its 52-week high of ₹1,270 — against a 13.9% ROE and a business that produced its first ₹346 crore profit year after two flat ones. The growth is real (profit up 87% in FY26, 35% revenue guidance for FY27) and the balance sheet is clean, but 75 times earnings on a working-capital-heavy contract manufacturer prices in the guidance being met, the margins holding, and the unproven PCB bet paying off. Anything short of continued flawless execution and the multiple, not the business, does the correcting.

Sources

Concall transcripts (4): Q1 FY26 (Jul 24, 2025), Q2 FY26 (Nov 11, 2025), Q3 FY26 (Jan 30, 2026), Q4 FY26 + full-year (May 12, 2026) — BSE filings, converted to markdown.
Annual reports (3): FY23, FY24, FY25 sections. Note: the trimmed FY24/FY25 extracts were thin (image-omitted MD&A and chairman’s letters), so the multi-year financial arc leans on the screener tables and the concalls.
Screener.in snapshot: quarterly and annual tables, ratios, shareholding — fetched 2026-06-07 (logged-out session).
Research files: vault/Sources/Earnings/Syrma SGS Technology Ltd/ — raw transcripts, AR sections, snapshot, per-document digests (not published).